Home/ Supplements/ Vitamin A/ Maxxum Basic

Maxxum Basic

product on market Capsule Karuna Safety: 99/100
99/100

This product looks safe

  • Vitamin B3: 200mg is 5.7× the Tolerable Upper Intake Level (35mg)
  • 73% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile contains a blend of essential fat-soluble and water-soluble vitamins that support immune function and cellular health. There is strong research evidence supporting the physiological roles of vitamins A, C, D3, E, and K1 in maintaining systemic wellness. The formulation maintains a high safety profile based on available data.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vitamin B3: 200mg is 5.7× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Maxxum Basic
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Multi-Vitamin and Mineral (MVM)
Product Type
73%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
5000 IU (100% DV)
Vitamin C
200 mg (333% DV)
1000 IU (250% DV)
1.7× RDA — within safe limits 608 studies (A:16, B:251)
200 IU (666% DV)
8.9× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)
120 mcg (150% DV)
Within RDA (1.0× RDA) 275 studies (A:9, B:175)
15 mg (1000% DV)
12.5× RDA — above typical dose 76 studies (A:0, B:33)
17 mg (1000% DV)
13.1× RDA — above typical dose 13 studies (A:0, B:1)
200 mg (1000% DV)
Exceeds UL by 5.7× (UL: 35 mg) 196 studies (A:5, B:63)
20 mg (1000% DV)
15.4× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
800 mcg (200% DV)
2.0× RDA — within safe limits 226 studies (A:10, B:105)
60 mcg (1000% DV)
25.0× RDA — above typical dose 139 studies (A:1, B:44)
300 mcg (100% DV)
10.0× RDA — above typical dose 27 studies (A:0, B:11)
100 mg (1000% DV)
20.0× RDA — above typical dose 2 studies — no high-quality reviews
Calcium
150 mg (15% DV)
150 mcg (100% DV)
Within RDA (1.0× RDA) 245 studies (A:4, B:133)
75 mg (19% DV)
Within RDA (0.2× RDA) 316 studies (A:8, B:159)
15 mg (100% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
1.5 mg (75% DV)
1.7× RDA — within safe limits 37 studies (A:0, B:11)
2.3 mg (115% DV)
Within RDA (1.0× RDA) 9 studies — no high-quality reviews
200 mcg (167% DV)
5.7× RDA — above typical dose 199 studies (A:1, B:55)
200 mcg (286% DV)
3.6× RDA — above typical dose (UL: 0.4 mg) 173 studies (A:0, B:67)
75 mcg (100% DV)
1.7× RDA — within safe limits 3 studies — no high-quality reviews

Other Ingredients

Capsule
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Suggested use for adults: Two capsules daily, with meals, or as directed by your health care practitioner.

Warnings & Precautions

This product is intended for professional use and is manufactured under strict quality control to ensure the optimum in purity, potency and reliability.

Formulation Notes

Two-A-Day High Potency Formulation of Vitamins and Minerals

This product contains no yeast, wheat, milk, salt, sugar, artificial coloring, preservatives or flavoring.

This product is intended for professional use and is manufactured under strict quality control to ensure the optimum in purity, potency and reliability.

Additional Information

Keep in a cool, dry place tightly capped.

Metadata

Product Details

UPC / SKU0 18647 01100 6
DSLD Entry Date2025-04-24
Product TypeMulti-Vitamin and Mineral (MVM)
FormCapsule
BrandKaruna
DSLD ID327097
Data Updated2026-04-11
Research

Research Evidence

337
Research Sources
54
Avg Quality
161
Meta Analysis
68
Systematic Review
51
Rct
48
Clinical Trial
2
Other
2
Regulatory Source
1
Narrative Review
1
Cochrane Review
1
Guideline
1
Openfda Safety
A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis
Meta Analysis BMJ (Clinical research ed.) 2011 PubMed DOI
A Fortification of staple foods with vitamin A for vitamin A deficiency
Systematic Review The Cochrane database of systematic reviews 2019 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
Narrative Review The Cochrane database of systematic reviews 2016 PubMed DOI
A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of sport and health science 2023 PubMed DOI
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
View all evidence for Vitamin A →
Compare

Similar Products

View all Vitamin A products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.